Literature DB >> 18367252

Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.

Arshud Dar1, Anil K Nichani, Ponn Benjamin, Ken Lai, Henry Soita, Arthur M Krieg, Andrew Potter, Lorne A Babiuk, George K Mutwiri.   

Abstract

The immune stimulatory effects of synthetic CpG DNA, on porcine peripheral blood mononuclear cells (PBMC) have been reported, but little is known about CpG-induced responses in other lymphoid tissues of pigs. We investigated innate immune responses induced by CpG DNA in cells from blood, lymph nodes (LN) and spleens of pigs. Porcine PBMC and lymph node cells (LNC) were stimulated in vitro with three classes (A-, B- and C-class) of CpG oligodeoxynucleotides (ODNs), and a non-CpG control ODN. All three classes of CpG ODNs induced significant production of IFNalpha, TNFalpha, IL-1, IL-6 and IL-12 in PBMC. In contrast, in LNC, only IL-12 was stimulated by all three classes of CpG ODNs, while IFNalpha, and IL-6 were induced by A- and C-class ODNs. No TNFalpha was induced in LNC by any of the ODNs. Significant lymphocyte proliferation was induced in PBMC by all three classes of CpG ODNs and non-CpG control. However, in LNC, B- and C-class ODNs induced significant proliferation, while no proliferation was seen with A-class and non-CpG control ODN. All three classes of ODNs induced NK-like cytotoxicity in PBMC and spleen cells, but were less effective in inducing NK cytotoxicity in LNC. We then investigated the reasons for the relatively poor CpG-induced responses in LNC. Our investigations revealed that LNC had a lower frequency of IFNalpha-secreting cells and expressed low levels of TLR9 mRNA compared to PBMC. We conclude that the lower number of IFNalpha-secreting cells and receptor expression may contribute to the attenuated responses in LNC following stimulation with CpG ODN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367252     DOI: 10.1016/j.vetimm.2008.02.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Modulatory effects of Lactobacillus salivarius on intestinal mucosal immunity of piglets.

Authors:  Jinhua Zhang; Jun Deng; Zhisheng Wang; Chuanyan Che; Yun-Feng Li; Qian Yang
Journal:  Curr Microbiol       Date:  2011-03-02       Impact factor: 2.188

2.  A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs.

Authors:  Marina R Facci; Gael Auray; Rachelle Buchanan; Jill van Kessel; David R Thompson; Sarah Mackenzie-Dyck; Lorne A Babiuk; Volker Gerdts
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

3.  Distinct peripheral blood RNA responses to Salmonella in pigs differing in Salmonella shedding levels: intersection of IFNG, TLR and miRNA pathways.

Authors:  Ting-Hua Huang; Jolita J Uthe; Shawn M D Bearson; Cumhur Yusuf Demirkale; Dan Nettleton; Susan Knetter; Curtis Christian; Amanda E Ramer-Tait; Michael J Wannemuehler; Christopher K Tuggle
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

4.  Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice.

Authors:  Wei Sun; Mingli Fang; Yajing Chen; Zhaogang Yang; Yue Xiao; Min Wan; Hua Wang; Yongli Yu; Liying Wang
Journal:  J Cancer       Date:  2016-01-05       Impact factor: 4.207

Review 5.  The porcine innate immune system: an update.

Authors:  K H Mair; C Sedlak; T Käser; A Pasternak; B Levast; W Gerner; A Saalmüller; A Summerfield; V Gerdts; H L Wilson; F Meurens
Journal:  Dev Comp Immunol       Date:  2014-04-04       Impact factor: 3.636

6.  Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts.

Authors:  Gael Auray; Marina R Facci; Jill van Kessel; Rachelle Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.